| 43.83 -0.22 (-0.5%) | 03-06 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 55.73  |
1-year : | 59.42 |
| Resists | First : | 47.71 |
Second : | 50.87 |
| Pivot price | 46.73  |
|||
| Supports | First : | 42.59 |
Second : | 35.44 |
| MAs | MA(5) : | 44.2 |
MA(20) : | 46.53 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | 0.6 |
| %K %D | K(14,3) : | 11.9 |
D(3) : | 14.9 |
| RSI | RSI(14): 42.8 |
|||
| 52-week | High : | 50.87 | Low : | 38 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ MDLN ] has closed above bottom band by 18.4%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 44.63 - 44.88 | 44.88 - 45.08 |
| Low: | 42.14 - 42.48 | 42.48 - 42.77 |
| Close: | 43.31 - 43.83 | 43.83 - 44.26 |
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services such as, consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. Medline Inc. was founded in 1966 and is based in Northfield, Illinois.
Wed, 04 Mar 2026
Is Medline (MDLN) Pricing Fair After Recent Share Price Slide? - Yahoo Finance
Wed, 04 Mar 2026
Evaluating Medline (MDLN) Valuation After Recent Fundamentals And Share Price Weakness - Sahm
Tue, 03 Mar 2026
Blackstone, Carlyle, Hellman & Friedman Offer 75M Shares For Medline - Medline (NASDAQ:MDLN) - Benzinga
Tue, 03 Mar 2026
Medline announces $3.6B secondary offering from private equity firms - MassDevice
Tue, 03 Mar 2026
Medline Inc. announces launch of secondary offering of Class A common stock - GlobeNewswire
Mon, 02 Mar 2026
Medline (NASDAQ:MDLN) Price Target Raised to $52.00 at Morgan Stanley - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 832 (M) |
| Shares Float | 9,120 (M) |
| Held by Insiders | 0.1 (%) |
| Held by Institutions | 98.2 (%) |
| Shares Short | 6,830 (K) |
| Shares Short P.Month | 12,890 (K) |
| EPS | 0.68 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.95 |
| Profit Margin | 4.6 % |
| Operating Margin | 8 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 11.3 % |
| Gross Profit (p.s.) | 8.96 |
| Sales Per Share | 32.96 |
| EBITDA (p.s.) | 3.9 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 1,440 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 63.52 |
| PEG Ratio | 0 |
| Price to Book value | 45.65 |
| Price to Sales | 1.32 |
| Price to Cash Flow | 25.33 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|